2024 Revenues ($USD) : $4.24B
Incyte reported strong revenue growth of 15% in 2024, reaching $4.2B, driven by strong performance from Jakafi (+8% to $2.8B) and Opzelura (+50% to $508M). The company has identified 2025 as "a year of defining catalysts" with at least 18 key milestones expected, including four new product launches and four pivotal study readouts. Management remains focused on achieving more than 10 impactful product launches by 2030.